• Implantica will host a Capital Markets Day in Stockholm on Sept. 9, 2026.
• Event will run 14:00-16:30 CEST at Sergelkonferensen, conference room “Wall Street.”
• Agenda will focus on plans following FDA clearance for RefluxStop, including strategy for a U.S. launch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Implantica AG published the original content used to generate this news brief via Cision (Ref. ID: 202608250200BITN____UKPR__EN_20260824-BIT-1534-0) on August 25, 2026, and is solely responsible for the information contained therein.